| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Kronos Bio, Inc. | Director | Stock Option (Right to Buy) | 34K | Jun 25, 2024 | Direct | ||
| Reneo Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 14.8K | Jun 6, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| KRON | Kronos Bio, Inc. | Jun 25, 2024 | 1 | $0 | 4 | Jun 26, 2024 | Director |
| KRON | Kronos Bio, Inc. | Jun 22, 2023 | 1 | $0 | 4 | Jun 26, 2023 | Director |
| RPHM | Reneo Pharmaceuticals, Inc. | Jun 6, 2023 | 1 | $0 | 4 | Jun 8, 2023 | Director |
| RPHM | Reneo Pharmaceuticals, Inc. | Aug 2, 2022 | 1 | $0 | 4 | Aug 2, 2022 | Director |
| RPHM | Reneo Pharmaceuticals, Inc. | Aug 2, 2022 | 0 | $0 | 3 | Aug 2, 2022 | Director |
| KRON | Kronos Bio, Inc. | Jun 22, 2022 | 1 | $0 | 4 | Jun 29, 2022 | Director |
| KRON | Kronos Bio, Inc. | Nov 11, 2021 | 1 | $0 | 4 | Nov 15, 2021 | Director |
| KRON | Kronos Bio, Inc. | Nov 11, 2021 | 0 | $0 | 3 | Nov 15, 2021 | Director |